Taylor KI, Probst A. Anatomic localization of the transentorhinal region of the perirhinal cortex. Aging. 2008 Oct;29(10):1591-6. Epub 2007 May 2. PMID 17478012[2]Archived 2011-03-31 at the Wayback Machine
Venneri A; Forbes-Mckay KE; Shanks MF (April 2005). "Impoverishment of Spontaneous Language and the Prediction of Alzheimer's Disease". Brain. 128 (Pt 4): E27. doi:10.1093/brain/awh419. PMID15788549.
Brookmeyer R, Johnson E, Ziegler-Graha K, Arrighi HM. Forecasting the global burden of Alzheimer’s disease. AlzheimersArchived 2023-06-01 at the Wayback Machine Dementia. 2007;3:186–191. PMID 19595937
Cooper GM: The Cell: A Molecular Approach. 2nd edition. Sunderland (MA): Sinauer Associates; 2000.[1]Archived 2019-10-29 at the Wayback Machine
Braak H, Braak E. Staging of Alzheimer's disease-related neurofibrillary changes. Neurobiol Aging. 1995 May-Jun;16(3):271-8; discussion 278-84. PMID 7566337
Weller RO, Preston SD, Subash M, Carare RO. Cerebral amyloid angiopathy in the aetiology and immunotherapy of AlzheimerArchived 2023-06-01 at the Wayback Machine disease. Alzheimers Res Ther. 2009 Oct 12;1(2):6. doi: 10.1186/alzrt6. PMID 19822028
Taylor KI, Probst A. Anatomic localization of the transentorhinal region of the perirhinal cortex. Aging. 2008 Oct;29(10):1591-6. Epub 2007 May 2. PMID 17478012[2]Archived 2011-03-31 at the Wayback Machine
G Binetti, E Magni, A Padovani et al. Executive dysfunction in early Alzheimer's disease. J Neurol Neurosurg Psychiatry. 1996 January; 60(1): 91–93.
PMCID PMC486198 [3]Archived 2022-03-23 at the Wayback Machine
Sperling RA, Aisen PS, Beckett LA, et al. Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Dement. 2011 May;7(3):280-92. doi: 10.1016/j.jalz.2011.03.003. Epub 2011 Apr 21. PMID 21514248
Commission de la transparence (June 2012). "Drugs for Alzheimer's disease: best avoided. No therapeutic advantage" [Drugs for Alzheimer's disease: best avoided. No therapeutic advantage]. Prescrire International. 21 (128): 150. PMID22822592.
Venneri A; Forbes-Mckay KE; Shanks MF (April 2005). "Impoverishment of Spontaneous Language and the Prediction of Alzheimer's Disease". Brain. 128 (Pt 4): E27. doi:10.1093/brain/awh419. PMID15788549.
Brookmeyer R, Johnson E, Ziegler-Graha K, Arrighi HM. Forecasting the global burden of Alzheimer’s disease. AlzheimersArchived 2023-06-01 at the Wayback Machine Dementia. 2007;3:186–191. PMID 19595937
Cooper GM: The Cell: A Molecular Approach. 2nd edition. Sunderland (MA): Sinauer Associates; 2000.[1]Archived 2019-10-29 at the Wayback Machine
Weller RO, Preston SD, Subash M, Carare RO. Cerebral amyloid angiopathy in the aetiology and immunotherapy of AlzheimerArchived 2023-06-01 at the Wayback Machine disease. Alzheimers Res Ther. 2009 Oct 12;1(2):6. doi: 10.1186/alzrt6. PMID 19822028
Taylor KI, Probst A. Anatomic localization of the transentorhinal region of the perirhinal cortex. Aging. 2008 Oct;29(10):1591-6. Epub 2007 May 2. PMID 17478012[2]Archived 2011-03-31 at the Wayback Machine
G Binetti, E Magni, A Padovani et al. Executive dysfunction in early Alzheimer's disease. J Neurol Neurosurg Psychiatry. 1996 January; 60(1): 91–93.
PMCID PMC486198 [3]Archived 2022-03-23 at the Wayback Machine
Brookmeyer R, Johnson E, Ziegler-Graha K, Arrighi HM. Forecasting the global burden of Alzheimer’s disease. AlzheimersArchived 2023-06-01 at the Wayback Machine Dementia. 2007;3:186–191. PMID 19595937
Weller RO, Preston SD, Subash M, Carare RO. Cerebral amyloid angiopathy in the aetiology and immunotherapy of AlzheimerArchived 2023-06-01 at the Wayback Machine disease. Alzheimers Res Ther. 2009 Oct 12;1(2):6. doi: 10.1186/alzrt6. PMID 19822028